Nisa Investment Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83K | Hold |
285
| – | – | ﹤0.01% | 2624 |
|
|
2025
Q1 | $1.01K | Sell |
285
-210
| -42% | -$743 | ﹤0.01% | 2637 |
|
|
2024
Q4 | $1.87K | Sell |
495
-250
| -34% | -$945 | ﹤0.01% | 2505 |
|
|
2024
Q3 | $2.41K | Buy |
745
+460
| +161% | +$1.49K | ﹤0.01% | 2359 |
|
|
2024
Q2 | $542 | Buy |
285
+275
| +2,750% | +$523 | ﹤0.01% | 2665 |
|
|
2024
Q1 | $28 | Sell |
10
-24
| -71% | -$67 | ﹤0.01% | 2767 |
|
|
2023
Q4 | $500 | Buy |
34
+18
| +113% | +$265 | ﹤0.01% | 2406 |
|
|
2023
Q3 | $293 | Sell |
16
-2
| -11% | -$37 | ﹤0.01% | 2617 |
|
|
2023
Q2 | $388 | Sell |
18
-8
| -31% | -$172 | ﹤0.01% | 2611 |
|
|
2023
Q1 | $1K | Hold |
26
| – | – | ﹤0.01% | 2345 |
|
|
2022
Q4 | $1K | Hold |
26
| – | – | ﹤0.01% | 2390 |
|
|
2022
Q3 | $1K | Buy |
+26
| New | +$1K | ﹤0.01% | 2387 |
|